Medicare won’t change coverage for expensive Alzheimer’s drugs

Medicare won't change coverage for expensive Alzheimer's drugs

Medicare will continue to limit coverage of a new class of Alzheimer’s drugs, even after they have been fully approved by the Food and Drug Administration (FDA). The Centers for Medicare and Medicaid Services (CMS) said in a statement Thursday that it will cover the drugs once they are fully approved but also require providers … Read more